Comments

Heron Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Heron Therapeutics (HRTX) operate in?

Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

HRTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Heron Therapeutics (HRTX) Forecast

News Earnings Heron Therapeutics (HRTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Heron Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:HRTX | Benzinga

Explore Heron Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HRTX.

Open	$1.90
Close	-
Volume / Avg.	565.33K / 2.00M
Day Range	$1.85 - $1.97
52 Wk Range	1.04 - 3.93
Market Cap	$286.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	28.38%
Days to Cover	33.1

Recent News

Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

FDA Expands Argenx's Vyvgart Label to Treat Rare Disorder

Shares of Argenx (NASDAQ: ARGX) rose nearly 4% on Friday after management announced that the FDA approved its subcutaneously administered Vyvgart Hytrulo (efgartigimod) for a second indication — chronic inflammatory demyelinating polyneuropathy (CIDP).

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.90
Close	-
Volume / Avg.	565.33K / 2.00M
Day Range	$1.85 - $1.97
52 Wk Range	1.04 - 3.93
Market Cap	$286.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	28.38%
Days to Cover	33.1

About Heron Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the l...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Heron Therapeutics (HRTX) stock?

You can purchase shares of Heron Therapeutics (NASDAQ:HRTX) through any online brokerage.

View our list of the best stock brokerages

Who are Heron Therapeutics (HRTX) competitors?

Other companies in Heron Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Inozyme Pharma (NASDAQ:INZY), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA) and Neurogene (NASDAQ:NGNE).

What is the forecast, or price target, for Heron Therapeutics (HRTX) stock?

Heron Therapeutics has a consensus price target of $6.75.

What is the current price for Heron Therapeutics (HRTX)?

The stock price for Heron Therapeutics (NASDAQ: HRTX) is $1.875 last updated May 21, 2025 at 2:29 PM EDT.

Does Heron Therapeutics (HRTX) pay a dividend?

There are no upcoming dividends for Heron Therapeutics.

When is Heron Therapeutics (NASDAQ:HRTX) reporting earnings?

Heron Therapeutics’s Q2 earnings are confirmed for Tuesday, August 5, 2025.

Is Heron Therapeutics (HRTX) going to split?

There is no upcoming split for Heron Therapeutics.

What sector and industry does Heron Therapeutics (HRTX) operate in?

Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.